Latest Dendreon Stories
LONDON, May 13, 2015 /PRNewswire/ -- INTRODUCTIONCancer is known to be one of the leading causes of death worldwide.
- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.
Bankruptcy Court formally approved Valeant's role as a stalking horse bidder LAVAL, Quebec, Feb. 5, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
LAVAL, Quebec, Jan. 29, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
New cutting-edge report “Dendritic Cell Cancer Vaccine Market & Clinical Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
DUBLIN, December 10, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/hzc93s/dendritic_cell) has announced the addition of
Ex-Vivo Manipulation of Autologous Hematopoietic Stem Cells Complements Dendritic Cell-based Vaccine Platform; Potential to Develop Single-Agent and Combination Immunotherapeutics LOS
-Conference Call and Webcast on September 12, 2014 at 8:30 a.m. ET, 5:30 a.m. PT- MENLO PARK, Calif. and LONDON, Sept.
Eighty-four percent of shareholder votes cast support annual election of board members. DETROIT, June 5, 2014 /PRNewswire/ -- Eighty-four percent (84%) of votes cast by shareholders
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).